AI assistant
Sending…
INOVIQ LTD — Capital/Financing Update 2016
Jun 16, 2016
65112_rns_2016-06-16_0c7741db-6aee-4de0-b8b9-ffe5c2fdba9e.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
(ACN 009 070 384)
==> picture [155 x 46] intentionally omitted <==
10 June 2016
The Manager Australian Securities Exchange 152-158 St George’s Terrace PERTH WA 6000
Dear Sir/Madam
The Company advises that the capital structure on re-quotation is as follows:
| Shares | Performance Shares | |
|---|---|---|
| Ordinary Shares | 322,493,350 | |
| Ordinary Shares (escrowed for24 Months from the date ofreinstatement to OfficialQuotation) | 229,503,236 | |
| Performance Shares (escrowedfor 24 Months from the date ofreinstatement to OfficialQuotation) | 217,003,236 |
Yours sincerely
==> picture [94 x 31] intentionally omitted <==
Pauline Collinson Company Secretary
BARD1 Life Sciences Limited (ABN 59 009 070 384) Suite B1, Tempo Building, 431 Roberts Road, Subiaco WA 6008 Tele: +618 93819550 Facsimile: +618 9388 7559
More from INOVIQ LTD
Director's Dealing
2026
May 25
Director's Dealing
2026
May 21
Director's Dealing
2026
May 18
Interim / Quarterly Report
2026
Apr 27
Director's Dealing
2026
Apr 1
Director's Dealing
2026
Mar 29
Director's Dealing
2026
Mar 12
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 22
Interim / Quarterly Report
2026
Feb 17